Lipotec, S.A.
Records under this name other than the patents Lipotec, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 16 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,815,266 | Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,993,716 | Peptides Used in the Treatment And/Or Care of the Skin, Mucous Membranes And/Or Hair and Its Use in Cosmetic or Pharmaceutical Compositions Formerly held In force · High confidence | In force | High confidence | |
| US 9,464,129 | Neuronal exocytosis inhibiting peptides Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,943,156 | Use of peptides of general formula I X-SEQ ID No.1-Y in the preparation of cosmetic compositions which are intended to improve the firmness of the skin by increasing cell adhesion Term ended Term ended Sep 20, 2025 · From the USPTO record | Term ended | Term ended Sep 20, 2025 | From the USPTO record |
| US 7,022,668 | Use of a glycoprotein for the treatment and re-epithelialisation of wounds Term ended Term ended Aug 28, 2022 · From the USPTO record | Term ended | Term ended Aug 28, 2022 | From the USPTO record |
| US 6,897,289 | Peptide synthesis procedure in solid phase Formerly held Term ended Term ended May 5, 2020 · From the USPTO record | Term ended | Term ended May 5, 2020 | From the USPTO record |
| US 7,015,192 | Neuronal Exocytosis Inhibiting Peptides and Cosmetic and Pharmaceutical Compositions Containing Said Peptides Term ended Term ended Feb 18, 2020 · High confidence | Term ended | Term ended Feb 18, 2020 | High confidence |
| US 7,473,679 | Treatments Employing Neuronal Exocytosis-Inhibiting Peptides Term ended Term ended Feb 18, 2020 · High confidence | Term ended | Term ended Feb 18, 2020 | High confidence |
| US 6,346,601 | Procedure for obtaining the somatostatin analog, octreotide Formerly held Term ended Term ended Jan 29, 2019 · From the USPTO record | Term ended | Term ended Jan 29, 2019 | From the USPTO record |
| US 8,110,207 | Pigmentation-regulating compounds Surrendered on reissue Surrendered on reissue Dec 6, 2016 · From the USPTO record | Surrendered on reissue | Surrendered on reissue Dec 6, 2016 | From the USPTO record |